Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 27 (September 20), 2005: pp. 6756-6762
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.15.255

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mankin, H. J.
Right arrow Articles by Gebhardt, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mankin, H. J.
Right arrow Articles by Gebhardt, M. C.

Aneurysmal Bone Cyst: A Review of 150 Patients

Henry J. Mankin, Francis J. Hornicek, Eduardo Ortiz-Cruz, Jorge Villafuerte, Mark C. Gebhardt

From the Orthopedic Oncology Service, Massachusetts General Hospital and Children's Hospital, Harvard Medical School, Boston, MA

Address reprint requests to Henry J. Mankin, MD, Orthopedic Surgery, Massachusetts General Hospital, Boston, MA 02114; e-mail: hmankin{at}partners.org

PURPOSE: We have reviewed a series of 150 aneurysmal bone cysts treated over the last 20 years.

PATIENTS AND METHODS: The lesions were principally located in the tibia, femur, pelvis, humerus, and spine and, in most cases, presented the imaging appearance originally described by Jaffe and Lichtenstein as a blowout with thin cortices.

RESULTS: Only one of the patients was believed to have an osteoblastoma of the spine with secondary development of an aneurysmal bone cyst, and none of the patients developed additional lesions. The patients were treated primarily with curettage and implantation of allograft chips or polymethylmethacrylate, but some patients were treated with insertion of autografts or allografts. The local recurrence rate was 20%, which is consistent with that reported by other centers.

CONCLUSION: Aneurysmal bone cysts are enigmatic lesions of unknown cause and presentation and are difficult to distinguish from other lesions. Overall, the treatment is satisfactory, but it is possible that newer approaches, such as improved magnetic resonance imaging studies, may help diagnose the lesions and allow the physicians to plan for more effective treatment protocols.

Authors' disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
JCOHome page
A. M. Oliveira, M. M. Chou, A. R. Perez-Atayde, and A. E. Rosenberg
Aneurysmal Bone Cyst: A Neoplasm Driven by Upregulation of the USP6 Oncogene
J. Clin. Oncol., January 1, 2006; 24(1): e1 - e1.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online